Aminothiazole

Aminothiazole

SCHEMBL6051173

Nc1nccs1.c1ccccc1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.88
HSD17B10 Q99714 2/20 0.88
TSHR P16473 1/20 0.88
NOS1 P29475 1/20 0.88
PDPK1 O15530 1/20 0.46
FBP1 P09467 2/20 0.42
PDK1 Q15118 1/20 0.42
GRM5 P41594 1/20 0.40
HSP90AA1 P07900 2/20 0.39
LOXL2 Q9Y4K0 1/20 0.35
CYP2A6 P11509 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ADORA2A P29274 2/20 0.35
GAA P10253 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ADORA1 P30542 1/20 0.34
AURKA O14965 1/20 0.34
PIM1 P11309 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminothiazole SCHEMBL27899272 0.94
Aminothiazole SCHEMBL4962431 0.94 ALDH1A1 (1.00) ALDH1A1HSD17B10TSHRNOS1PDPK1
Aminothiazole SCHEMBL1136755 0.94
Aminothiazole SCHEMBL7401 0.94
Aminothiazole SCHEMBL10428703 0.94
Aminothiazole SCHEMBL5781624 0.91
Aminothiazole SCHEMBL1641818 0.91
Aminothiazole SCHEMBL7469112 0.91
Aminothiazole SCHEMBL2350289 0.91
Aminothiazole SCHEMBL7473421 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1686949-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES Viropharma Incorporated (US) 2006-08-09 EP disclosed
WO-2005051318-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES VIROPHARMA INCORPORATED (US) 2005-06-09 WO disclosed